Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study will compare the effectiveness (how well the drug works) of aripiprazole, flexibly
dosed with a placebo, in reducing serious behavioral problems in children and adolescents
with a diagnosis of autistic disorder (AD).
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.